Fluarix BLA filed
Executive Summary
GlaxoSmithKline announced May 25 the submission of a BLA for its influenza agent Fluarix. In early May, GSK said it plans to provide 10 mil. doses of the product for the 2005-06 flu season and that it had already started the manufacturing ramp-up (1"The Pink Sheet" May 9, 2005, In Brief)...
You may also be interested in...
2005-2006 flu vaccine
GlaxoSmithKline plans to provide up to 10 mil. doses of Fluarix influenza vaccine for the upcoming season. GSK says it has started the manufacturing ramp up and the Fluarix BLA will be submitted in mid '05, possibly as early as late May...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.